3D Organotypic Cultures of Human HepaRG Cells: A Tool for In Vitro Toxicity Studies
Open accessThe DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Abstract
Drug-induced human hepatotoxicity is difficult to predict using the current in vitro systems. In this study, long-term 3D organotypic cultures of the human hepatoma HepaRG cell line were prepared using a high-throughput hanging drop method. The organotypic cultures were maintained for 3 weeks and assessed for (1) liver specific functions, including phase I enzyme and transporter activities, (2) expression of liver-specific proteins, and (3) responses to three drugs (acetaminophen, troglitazone, and rosiglitazone). Our results show that the organotypic cultures maintain high liver-specific functionality during 3 weeks of culture. The immunohistochemistry analyses illustrate that the organotypic cultures express liver-specific markers such as albumin, CYP3A4, CYP2E1, and MRP-2 throughout the cultivation period. Accordingly, the production rates of albumin and glucose, as well as CYP2E1 activity, were significantly higher in the 3D versus the 2D cultures. Toxicity studies show that the organotypic cultures are more sensitive to acetaminophen- and rosiglitazone-induced toxicity but less sensitive to troglitazone-induced toxicity than the 2D cultures. Furthermore, the EC50 value (2.7mM) for acetaminophen on the 3D cultures was similar to in vivo toxicity. In summary, the results from our study suggest that the 3D organotypic HepaRG culture is a promising in vitro tool for more accurate assessment of acute and also possibly for chronic drug-induced hepatotoxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The observed increased sensitivity in the 3D hLiMT versus the traditional 2D culture model is consistent with reports that 3D spheroid models produce better risk assessment of drug-induced hepatotoxicity (Gunness et al. 2013).”
From Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury (2017) · cites this paper as Gunness et al. 2013
Citations
Cites
Capturing complex 3D tissue physiology in vitro
Griffith, L. G., & Swartz, M. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1858 · Cited by 2,290
ACETAMINOPHEN-INDUCED HEPATIC NECROSIS. I. ROLE OF DRUG METABOLISM
Mitchell, J. R., Jollow, D. J., Potter, W. Z., Davis, D. C., Gillette, J. R., & Brodie, B. B. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29663-x · Cited by 1,498
Infection of a human hepatoma cell line by hepatitis B virus
Gripon, P., Rumin, S., Urban, S., Le Seyec, J., Glaise, D., Cannie, I., Guyomard, C., Lucas, J., Trepo, C., & Guguen-Guillouzo, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232137699 · Cited by 1,282
Recent advances in three‐dimensional multicellular spheroid culture for biomedical research
Lin, R., & Chang, H. (2008) · Biotechnology Journal · doi:10.1002/biot.200700228 · Cited by 1,264 · cited 3×
“, 2008), which is imperative for normal cell physiology and function (Griffith and Swartz, 2006; Lin et al., 2008; van Zijl and Mikulits, 2010).”
BackgroundAcetaminophen-induced Hepatic Necrosis
Jollow, D. J., Thorgeirsson, S. S., Potter, W. Z., Hashimoto, M., & Mitchell, J. R. (1974) · Pharmacology · doi:10.1159/000136547 · Cited by 1,092
Kelm, J. M., Timmins, N. E., Brown, C. J., Fussenegger, M., & Nielsen, L. K. (2003) · Biotechnology and Bioengineering · doi:10.1002/bit.10655 · Cited by 934
Aninat, C., Piton, A., Glaise, D., Le Charpentier, T., Langouët, S., Morel, F., Guguen-Guillouzo, C., & Guillouzo, A. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006759 · Cited by 703
Guillouzo, A., Corlu, A., Aninat, C., Glaise, D., Morel, F., & Guguen-Guillouzo, C. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2006.12.003 · Cited by 675
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Liver cell models in in vitro toxicology.
Guillouzo, A. (1998) · Environmental Health Perspectives · doi:10.1289/ehp.98106511 · Cited by 385
Cerec, V., Glaise, D., Garnier, D., Morosan, S., Turlin, B., Drenou, B., Gripon, P., Kremsdorf, D., Guguen‐Guillouzo, C., & Corlu, A. (2007) · Hepatology · doi:10.1002/hep.21536 · Cited by 371
Evaluation of HepaRG Cells as an in Vitro Model for Human Drug Metabolism Studies
Kanebratt, K. P., & Andersson, T. B. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.020016 · Cited by 354
Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000180q · Cited by 311
Dynamic analysis of hepatoma spheroid formation: roles of E-cadherin and β1-integrin
Lin, R.-Z., Chou, L.-F., Chien, C.-C. M., & Chang, H.-Y. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0148-2 · Cited by 305 · cited 1×
“In the hanging drop system, the formation of spheroids is induced by integrin-extracellular matrix binding followed by cadherin-cadherin interactions, resulting in strong cell-cell adhesion (Lin et al., 2006).”
BackgroundMicroscale tissue engineering using gravity-enforced cell assembly
Kelm, J. M., & Fussenegger, M. (2004) · Trends in Biotechnology · doi:10.1016/j.tibtech.2004.02.002 · Cited by 297
Funk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
HepaRG Cells: A Human Model to Study Mechanisms of Acetaminophen Hepatotoxicity Δσ
McGill, M. R., Yan, H.-M., Ramachandran, A., Murray, G. J., Rollins, D. E., & Jaeschke, H. (2011) · Hepatology · doi:10.1002/hep.24132 · Cited by 294
Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition
Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 238
Godoy, P., Hengstler, J. G., Ilkavets, I., Meyer, C., Bachmann, A., Müller, A., Tuschl, G., Mueller, S. O., & Dooley, S. (2009) · Hepatology · doi:10.1002/hep.22880 · Cited by 234
Structural Polarity and Functional Bile Canaliculi in Rat Hepatocyte Spheroids
Abu-Absi, S. F., Friend, J. R., Hansen, L. K., & Hu, W.-S. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5467 · Cited by 230
Bokhari, M., Carnachan, R. J., Cameron, N. R., & Przyborski, S. A. (2007) · Journal of Anatomy · doi:10.1111/j.1469-7580.2007.00778.x · Cited by 227
Shiau, C.-W., Yang, C.-C., Kulp, S. K., Chen, K.-F., Chen, C.-S., Huang, J.-W., & Chen, C.-S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1677 · Cited by 222
Jossé, R., Aninat, C., Glaise, D., Dumont, J., Fessard, V., Morel, F., Poul, J.-M., Guguen-Guillouzo, C., & Guillouzo, A. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.019901 · Cited by 187
Coecke, S., Ahr, H., Blaauboer, B. J., Bremer, S., Casati, S., Castell, J., Combes, R., Corvi, R., Crespi, C. L., Cunningham, M. L., et al. (2006) · Alternatives to Laboratory Animals · doi:10.1177/026119290603400113 · Cited by 180
Self-citationOptimization of the HepaRG cell model for drug metabolism and toxicity studies
Anthérieu, S., Chesné, C., Li, R., Guguen-Guillouzo, C., & Guillouzo, A. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.05.008 · Cited by 177
Bedoucha, M., Atzpodien, E., & Boelsterli, U. A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00066-6 · Cited by 169
Clark, S., Francis, P. S., Conlan, X. A., & Barnett, N. W. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.05.085 · Cited by 135
Paracetamol (acetaminophen) pharmacodynamics: interpreting the plasma concentration
Gibb, I. A., & Anderson, B. J. (2007) · Archives of Disease in Childhood · doi:10.1136/adc.2007.126896 · Cited by 132
Design of Artificial Myocardial Microtissues
Kelm, J. M., Ehler, E., Nielsen, L. K., Schlatter, S., Perriard, J.-C., & Fussenegger, M. (2004) · Tissue Engineering · doi:10.1089/107632704322791853 · Cited by 127
Troglitazone and liver injury: In search of answers†
Chojkier, M. (2005) · Hepatology · doi:10.1002/hep.20567 · Cited by 125
Drewitz, M., Helbling, M., Fried, N., Bieri, M., Moritz, W., Lichtenberg, J., & Kelm, J. M. (2011) · Biotechnology Journal · doi:10.1002/biot.201100290 · Cited by 124
Nozawa, T., Sugiura, S., Nakajima, M., Goto, A., Yokoi, T., Nezu, J., Tsuji, A., & Tamai, I. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.291 · Cited by 121
Zeilinger, K., Schreiter, T., Darnell, M., Söderdahl, T., Lübberstedt, M., Dillner, B., Knobeloch, D., Nüssler, A. K., Gerlach, J. C., & Andersson, T. B. (2011) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0580 · Cited by 118
He, K., Talaat, R. E., Pool, W. F., Reily, M. D., Reed, J. E., Bridges, A. J., & Woolf, T. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.639 · Cited by 115
Liver fibrosis in vitro: Cell culture models and precision-cut liver slices
van de Bovenkamp, M., Groothuis, G. M. M., Meijer, D. K. F., & Olinga, P. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.12.009 · Cited by 110
Three-Dimensional HepaRG Model As An Attractive Tool for Toxicity Testing
Leite, S. B., Wilk-Zasadna, I., Zaldivar, J. M., Airola, E., Reis-Fernandes, M. A., Mennecozzi, M., Guguen-Guillouzo, C., Chesne, C., Guillou, C., Alves, P. M., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs232 · Cited by 103
Miranda, J. P., Rodrigues, A., Tostões, R. M., Leite, S., Zimmerman, H., Carrondo, M. J. T., & Alves, P. M. (2010) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2009.0784 · Cited by 102
Masubuchi, Y., Kano, S., & Horie, T. (2006) · Toxicology · doi:10.1016/j.tox.2006.02.017 · Cited by 100
Hepatotoxicity of thiazolidinediones
Isley, W. L. (2003) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2.6.581 · Cited by 99
Bazou, D., Coakley, W. T., Hayes, A. J., & Jackson, S. K. (2008) · Toxicology in Vitro · doi:10.1016/j.tiv.2008.03.014 · Cited by 96
Enzyme-Induction Dependent Bioactivation of Troglitazone and Troglitazone Quinone In Vivo
Tettey, J. N. A., Maggs, J. L., Rapeport, G., Pirmohamed, M., & Park, B. K. (2001) · Chemical Research in Toxicology · doi:10.1021/tx0001981 · Cited by 96
Formation of a Novel Quinone Epoxide Metabolite of Troglitazone with Cytotoxic to HepG2 Cells
Yamamoto, Y., Yamazaki, H., Ikeda, T., Watanabe, T., Iwabuchi, H., Nakajima, M., & Yokoi, T. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.155 · Cited by 84
Darnell, M., Schreiter, T., Zeilinger, K., Urbaniak, T., Söderdahl, T., Rossberg, I., Dillnér, B., Berg, A., Gerlach, J. C., & Andersson, T. B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.037721 · Cited by 83
Towards an Extended Functional Hepatocyte In Vitro Culture
Miranda, J. P., Leite, S. B., Muller-Vieira, U., Rodrigues, A., Carrondo, M. J. T., & Alves, P. M. (2009) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2008.0352 · Cited by 81
Knockaert, L., Descatoire, V., Vadrot, N., Fromenty, B., & Robin, M. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.11.019 · Cited by 81
Liver Cell Models in in Vitro Toxicology
Guillouzo, A. (1998) · Environmental Health Perspectives · doi:10.2307/3433803 · Cited by 79
Lim, P. L. K., Liu, J., Go, M. L., & Boelsterli, U. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfm273 · Cited by 75
Darnell, M., Ulvestad, M., Ellis, E. C. S., Weidolf, L. O. G., & Andersson, T. B. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.195834 · Cited by 74
Sakai, Y., Yamagami, S., & Nakazawa, K. (2010) · Cells Tissues Organs · doi:10.1159/000272316 · Cited by 72
Ogimura, E., Sekine, S., & Horie, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.032 · Cited by 69
Hepatospheres: Three dimensional cell cultures resemble physiological conditions of the liver
Zijl, F. V., & Mikulits, W. (2010) · World Journal of Hepatology · doi:10.4254/wjh.v2.i1.1 · Cited by 67
Oshikata, A., Matsushita, T., & Ueoka, R. (2011) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2011.01.006 · Cited by 62
Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism
Tuschl, G., Lauer, B., & Mueller, S. O. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.855 · Cited by 62
Lipscomb, J. C., Teuschler, L. K., Swartout, J., Popken, D. A., Cox, T., & Kedderis, G. L. (2003) · Risk Analysis · doi:10.1111/j.0272-4332.2003.00397.x · Cited by 57
Bae, M., Rhee, H. M., & Song, B. J. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00468-x · Cited by 56
Niklas, J., Noor, F., & Heinzle, E. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.005 · Cited by 56
Self-citationTroglitazone Hepatotoxicity: Are We Getting Closer to Understanding Idiosyncratic Liver Injury?
Jaeschke, H. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm021 · Cited by 55
Pérez‐Ortiz, J. M., Tranque, P., Burgos, M., Vaquero, C. F., & Llopis, J. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032458 · Cited by 53
Sigrist, S., Bedoucha, M., & Boelsterli, U. A. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00299-9 · Cited by 51
Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model
Edling, Y., Sivertsson, L., Butura, A., Ingelman‐Sundberg, M., & Ek, M. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.07.026 · Cited by 50
Self-citationLloyd, S., Hayden, M. J., Sakai, Y., Fackett, A., Silber, P. M., Hewitt, N. J., & Li, A. P. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00054-6 · Cited by 46
In-depth physiological characterization of primary human hepatocytes in a 3D hollow-fiber bioreactor
Mueller, D., Tascher, G., Müller-Vieira, U., Knobeloch, D., Nuessler, A. K., Zeilinger, K., Heinzle, E., & Noor, F. (2011) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.418 · Cited by 43
Self-citationToxic Metabolite Formation from Troglitazone (TGZ): New Insights from a DFT Study
Dixit, V. A., & Bharatam, P. V. (2011) · Chemical Research in Toxicology · doi:10.1021/tx200110h · Cited by 39
Organotypic Cultures of Hepg2 Cells for In Vitro Toxicity Studies
Mueller, D., Koetemann, A., & Noor, F. (2011) · Journal of Bioengineering and Biomedical Sciences · doi:10.4172/2155-9538.s2-002 · Cited by 39
Self-citationSaha, S., Chan, D. S. Z., Lee, C. Y., Wong, W., New, L. S., Chui, W. K., Yap, C. W., Chan, E. C. Y., & Ho, H. K. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.09.021 · Cited by 38
Kim, J.-A., Han, E., Eun, C.-J., Tak, Y. K., & Song, J. M. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.08.027 · Cited by 34
Phillips, J. W., Jones, M. E., & Berry, M. N. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02687.x · Cited by 26
Troglitazone prevents fatty changes of the liver in obese diabetic rats
Jia, D. M., Tabaru, A., Akiyama, T., Abe, S., & Otsuki, M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02316.x · Cited by 24
Strigun, A., Wahrheit, J., Beckers, S., Heinzle, E., & Noor, F. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.02.008 · Cited by 21
Self-citationReal-time in situ viability assessment in a 3D bioreactor with liver cells using resazurin assay
Mueller, D., Tascher, G., Damm, G., Nussler, A. K., Heinzle, E., & Noor, F. (2012) · Cytotechnology · doi:10.1007/s10616-012-9486-6 · Cited by 16
Self-citationEffect of troglitazone on the liver of a Gunn rat model of genetic enzyme polymorphism.
Watanabe, T., Furukawa, T., Sharyo, S., et al. (2000) · The Journal of Toxicological Sciences · doi:10.2131/jts.25.5_423 · Cited by 13
Gene expression of liver-specific proteins in hepatocyte spheroids in primary culture.
Tamura, T., Koide, N., Hada, H., Shiraha, H., & Tsuji, T. (1995) · PubMed · doi:10.18926/amo/30405 · Cited by 11
Futile Cycles Revisited: A Markov Chain Model of Simultaneous Glycolysis and Gluconeogenesis
Jones, M. E., Berry, M. N., & Phillips, J. W. (2002) · Journal of Theoretical Biology · doi:10.1006/jtbi.2002.3042 · Cited by 9
Research works printed but not linked: 1
- Watanabe, (1999), Was it not possible to predict liver dysfunction caused by troglitazone during the nonclinical safety studies?, Reevaluat. Safe, 30, 537
Cited by
Three-Dimensional Cell Cultures in Drug Discovery and Development
Fang, Y., & Eglen, R. M. (2017) · SLAS Discovery · doi:10.1177/1087057117696795 · Cited by 849
“Human liver organoids obtained using HepaRG cell line, a terminally differentiated hepatic cell line derived from a human hepatic progenitor cell line, have already been shown to produce human-specific metabolites.(117) This is particularly useful because human liver often metabolizes drugs in a manner distinct from a…”
BackgroundMethodNunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.26845 · Cited by 721
Complexity of dopamine metabolism
Meiser, J., Weindl, D., & Hiller, K. (2013) · Cell Communication and Signaling · doi:10.1186/1478-811x-11-34 · Cited by 663
Ramaiahgari, S. C., den Braver, M. W., Herpers, B., Terpstra, V., Commandeur, J. N. M., van de Water, B., & Price, L. S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1215-9 · Cited by 364
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328
“The observed increased sensitivity in the 3D hLiMT versus the traditional 2D culture model is consistent with reports that 3D spheroid models produce better risk assessment of drug-induced hepatotoxicity (Gunness et al. 2013).”
Result
Metadata
- Authors
- Gunness, P., Mueller, D., Shevchenko, V., Heinzle, E., Ingelman-Sundberg, M., & Noor, F.
- Affiliations
- Karolinska Institutet (SE)
- Saarland University (DE)
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-02-01
- Volume
- 133
- Issue
- 1
- Pages
- 67-78
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2143495342
- Cited by
- 236
- References
- 73
- Citations by year
- 2026: 9 · 2025: 7 · 2024: 15 · 2023: 6 · 2022: 16 · 2021: 18 · 2020: 25 · 2019: 23 · 2018: 23 · 2017: 23 · 2016: 24 · 2015: 20 · 2014: 22 · 2013: 5
- FWCI
- 25.83
- Type
- journal article
- Language
- en
- Open access
- green
- orbilu.uni.lu
- Licence
- cc-by-nc-sa
- Locations
- Toxicological Sciences (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
- Funders
- McGill University
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- HepaRG cells, 3D organotypic culture, drug-induced liver injury, acetaminophen toxicity, rosiglitazone, troglitazone, CYP2E1, CYP3A4, MRP2, albumin synthesis, phase I enzymes, drug transporters, in vitro toxicity testing, hanging drop method
- MeSH terms
- Cytochrome P450 Family 2, Rosiglitazone, Troglitazone, Acetaminophen, Multidrug Resistance-Associated Protein 2, ATP-Binding Cassette Sub-Family B Member 4, Albumins, Chromans, Cytochrome P-450 Enzyme System, Humans, Liver, Urea, ATP Binding Cassette Transporter, Subfamily B, Spheroids, Cellular, Cell Culture Techniques, Hepatocytes, Toxicity Tests, Acute, Thiazolidinediones, Cell Line, Tumor, High-Throughput Screening Assays
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.